Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
ENZON PHARMACEUTICALS, INC. (ENZN)
|
Add to portfolio |
|
|
|
| Price: |
$0.70
| | Metrics |
| OS: |
74.2
|
M
| |
|
|
| Market cap: |
$52
|
M
| |
|
|
|
Net cash:
|
$46.1
|
M
| |
$0.62
|
per share
|
|
EV:
|
$5.82
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($1.1)
|
M
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 0.7 | 0.1 | 0.2 | 6.9 | 8.4 | 8.4 | 17.5 | 31.2 |
| Revenue growth | 1248.1% | -74.9% | -97.0% | -17.4% | 0.0% | -52.0% | -44.0% | -9.6% |
| Cost of goods sold | 1.2 | 1.4 | 1.2 | 1.1 | 1.4 | 1.7 | 6.7 | 2.4 |
| Gross profit | -0.5 | -1.3 | -1.0 | 5.9 | 7.0 | 6.6 | 10.8 | 28.8 |
| Gross margin | -66.9% | -2509.6% | -470.0% | 84.6% | 83.6% | 79.3% | 61.9% | 92.4% |
| Selling, general and administrative | 0.0 | 0.0 | 0.0 | | | | 2.2 | 0.0 |
| Research and development | | | | | | | | |
| General and administrative | 1.2 | 1.4 | 1.2 | 1.1 | 1.4 | 1.7 | | 0.0 |
| EBIT | -0.5 | -1.3 | -1.0 | 4.8 | 5.6 | 6.7 | 15.3 | 28.8 |
| EBIT margin | -66.9% | -2509.6% | -470.0% | 69.3% | 67.3% | 80.0% | 87.7% | 92.4% |
| Pre-tax income | -0.5 | -1.3 | -1.0 | 5.9 | 7.0 | 6.6 | 10.8 | 28.9 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 1.6 | 7.8 | -10.8 | 0.1 |
| Tax rate | | | | 0.1% | 22.3% | 116.9% | | 0.2% |
| Net income | -2.5 | -1.8 | -1.0 | 5.8 | 5.4 | -1.1 | 21.6 | 28.8 |
| Net margin | -355.5% | -3405.8% | -472.9% | 84.5% | 65.0% | -13.4% | 124.0% | 92.4% |
| |
| Diluted EPS | ($33.58) | ($34.66) | ($0.02) | $0.13 | $0.12 | ($0.03) | $0.49 | $0.65 |
| Shares outstanding (diluted) | 0.1 | 0.1 | 44.2 | 44.2 | 44.2 | 44.2 | 44.2 | 44.2 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|